Live rubella virus vaccine long-term persistence as an antigenic trigger of cutaneous granulomas in patients with primary immunodeficiency
Christine Bodemer(Hôpital Necker-Enfants Malades), Marc Éloit(Hydroquest (France)), Alain Fischer(Inserm), Justine Cheval, Virginie Sauvage, Stéphane Blanche(Hôpital Necker-Enfants Malades), Nizar Mahlaoui(Hôpital Necker-Enfants Malades), Thérèse Couderc(Inserm), Marc Lecuit(Inserm), Léa Gagnieur(Institut Pasteur), Sylvie Fraïtag(Délégation Paris 5), Isabelle Pellier(Centre National de la Recherche Scientifique), Marianne Debré, Stéphanie Leclerc‐Mercier(Institut Européen De La Qualité Totale)
Cited by 92
Related Papers
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
|Science|2020|3.2k
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
|Science|2000|2.6k
A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined Immunodeficiency
|New England Journal of Medicine|2003|1.8k
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
|Journal of Clinical Investigation|2008|1.8k